These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 34027650)

  • 61. Storm at the Time of Corona: A Glimpse at the Current Understanding and Therapeutic Opportunities of the SARS-CoV-2 Cytokine Storm.
    Torabi-Rahvar M; Rezaei N
    Curr Pharm Des; 2021; 27(13):1549-1552. PubMed ID: 33238863
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Can BCG vaccine protect against COVID-19 via trained immunity and tolerogenesis?
    Basak P; Sachdeva N; Dayal D
    Bioessays; 2021 Mar; 43(3):e2000200. PubMed ID: 33169410
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Hazards of the Cytokine Storm and Cytokine-Targeted Therapy in Patients With COVID-19: Review.
    Quirch M; Lee J; Rehman S
    J Med Internet Res; 2020 Aug; 22(8):e20193. PubMed ID: 32707537
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Complement cascade in severe forms of COVID-19: Recent advances in therapy.
    Chouaki Benmansour N; Carvelli J; Vivier E
    Eur J Immunol; 2021 Jul; 51(7):1652-1659. PubMed ID: 33738806
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Mesenchymal stem cell immunomodulation: In pursuit of controlling COVID-19 related cytokine storm.
    Song N; Wakimoto H; Rossignoli F; Bhere D; Ciccocioppo R; Chen KS; Khalsa JK; Mastrolia I; Samarelli AV; Dominici M; Shah K
    Stem Cells; 2021 Jun; 39(6):707-722. PubMed ID: 33586320
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Rifampicin and Letermovir as potential repurposed drug candidate for COVID-19 treatment: insights from an in-silico study.
    Pathak Y; Mishra A; Choudhir G; Kumar A; Tripathi V
    Pharmacol Rep; 2021 Jun; 73(3):926-938. PubMed ID: 33970450
    [TBL] [Abstract][Full Text] [Related]  

  • 67.
    Khan FI; Hassan F; Lai D
    Front Immunol; 2021; 12():794780. PubMed ID: 35095870
    [TBL] [Abstract][Full Text] [Related]  

  • 68. SARS-CoV-2 multifaceted interaction with the human host. Part II: Innate immunity response, immunopathology, and epigenetics.
    Beacon TH; Su RC; Lakowski TM; Delcuve GP; Davie JR
    IUBMB Life; 2020 Nov; 72(11):2331-2354. PubMed ID: 32936531
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cytokine Storm: The Primary Determinant for the Pathophysiological Evolution of COVID-19 Deterioration.
    Chen R; Lan Z; Ye J; Pang L; Liu Y; Wu W; Qin X; Guo Y; Zhang P
    Front Immunol; 2021; 12():589095. PubMed ID: 33995341
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19?
    Panigrahy D; Gilligan MM; Huang S; Gartung A; Cortés-Puch I; Sime PJ; Phipps RP; Serhan CN; Hammock BD
    Cancer Metastasis Rev; 2020 Jun; 39(2):337-340. PubMed ID: 32385712
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Flavonoids against the SARS-CoV-2 induced inflammatory storm.
    Liskova A; Samec M; Koklesova L; Samuel SM; Zhai K; Al-Ishaq RK; Abotaleb M; Nosal V; Kajo K; Ashrafizadeh M; Zarrabi A; Brockmueller A; Shakibaei M; Sabaka P; Mozos I; Ullrich D; Prosecky R; La Rocca G; Caprnda M; Büsselberg D; Rodrigo L; Kruzliak P; Kubatka P
    Biomed Pharmacother; 2021 Jun; 138():111430. PubMed ID: 33662680
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cytokine storm in COVID-19 and parthenolide: Preclinical evidence.
    Bahrami M; Kamalinejad M; Latifi SA; Seif F; Dadmehr M
    Phytother Res; 2020 Oct; 34(10):2429-2430. PubMed ID: 32472655
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Medicinal Plants and Zinc: Impact on COVID-19 Pandemic.
    Jalal Z; Bakour M; Lyoussi B
    ScientificWorldJournal; 2021; 2021():9632034. PubMed ID: 34602868
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Induction of Innate Immune Response by TLR3 Agonist Protects Mice against SARS-CoV-2 Infection.
    Tamir H; Melamed S; Erez N; Politi B; Yahalom-Ronen Y; Achdout H; Lazar S; Gutman H; Avraham R; Weiss S; Paran N; Israely T
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215785
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Plants and Natural Products with Activity against Various Types of Coronaviruses: A Review with Focus on SARS-CoV-2.
    Llivisaca-Contreras SA; Naranjo-Morán J; Pino-Acosta A; Pieters L; Vanden Berghe W; Manzano P; Vargas-Pérez J; León-Tamariz F; Cevallos-Cevallos JM
    Molecules; 2021 Jul; 26(13):. PubMed ID: 34279439
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Can molecular mimicry explain the cytokine storm of SARS-CoV-2?: An in silico approach.
    Obando-Pereda G
    J Med Virol; 2021 Sep; 93(9):5350-5357. PubMed ID: 33913542
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Implications for Neuromodulation Therapy to Control Inflammation and Related Organ Dysfunction in COVID-19.
    Fudim M; Qadri YJ; Ghadimi K; MacLeod DB; Molinger J; Piccini JP; Whittle J; Wischmeyer PE; Patel MR; Ulloa L
    J Cardiovasc Transl Res; 2020 Dec; 13(6):894-899. PubMed ID: 32458400
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A Potential Role of Interleukin 10 in COVID-19 Pathogenesis.
    Lu L; Zhang H; Dauphars DJ; He YW
    Trends Immunol; 2021 Jan; 42(1):3-5. PubMed ID: 33214057
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Clinical significance of measuring serum cytokine levels as inflammatory biomarkers in adult and pediatric COVID-19 cases: A review.
    Liu BM; Martins TB; Peterson LK; Hill HR
    Cytokine; 2021 Jun; 142():155478. PubMed ID: 33667962
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Flavonoids as potential phytotherapeutics to combat cytokine storm in SARS-CoV-2.
    Gour A; Manhas D; Bag S; Gorain B; Nandi U
    Phytother Res; 2021 Aug; 35(8):4258-4283. PubMed ID: 33786876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.